Top 10 Companies in Europe Haematococcus Pluvialis Market

The Europe Haematococcus Pluvialis Market is projected to reach $35.0 million by 2030, at a CAGR of 13.4% from 2023 to 2030. The growth of this market is driven by increasing demand for natural astaxanthin for nutraceuticals, growing demand for natural food colorants, and increasing awareness of clean-label products. However, the high production cost is expected to restrain the growth of this market.

Here are the top 10 companies operating in the Europe Haematococcus Pluvialis Market

Cyanotech Corporation (U.S.)

Founded in 1983 and headquartered in Kailua-Kona, U.S., Cyanotech is engaged in the cultivation and production of natural products derived from microalgae for health and human dietary supplements. The company operates through three business segments, namely, Natural Astaxanthin Products, Spirulina Products, and Contract Extraction Services. The company has microalgae cultivation ponds and offers spirulina in powder and tablet forms and astaxanthin in the form of oleoresin, powder, and soft gels.

Cyanotech caters to food, agriculture, animal feed, dietary supplement, nutraceutical, and cosmetic industries. With its subsidiaries and a strong distribution network, it has a geographic presence across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. As of March 2022, the company had a headcount of 95 employees.

E.I.D. – Parry (India) Limited (A Subsidiary of M/S. Ambadi Investments Limited) (India)

Founded in 1788 and headquartered in Chennai, India, E.I.D. – Parry is engaged in the manufacturing of sugar, biopesticides, and nutraceuticals. The company’s four product segments are Sugar, Cogeneration, Distillery, and Nutraceuticals. The Nutraceuticals segment offers organic spirulina, chlorella, astaxanthin, and microalgal products.

E.I.D. offers its products to the confectionery, bakery, beverages, and dairy industries. The company offers organic spirulina products such as phycocyanin in the nutraceuticals space. With its subsidiaries and a strong distribution network in over 41 countries, the company has a geographic presence across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. As of March 2022, the company had a headcount of 2,068 employees worldwide.

DAESANG Corporation (Korea)

Founded in 1956 and headquartered in Seoul, Korea, DAESANG produces a variety of food products, including food seasonings, sweeteners, starches, coffee, fodder, bulk pharmaceutical ingredients, spicy condiments, such as hot pepper and soybean pastes, soy sauce, marinades, fish sauce, bouillon, vinegar, mayonnaise, and instant noodles. The company is one of the country’s top corn wet millers and manufactures corn starch, corn syrup, and starches for industrial applications, such as adhesives.

Daesang operates through two major business segments, namely, Food and Ingredient. The Ingredient segment offers microalgae products. It provides chlorella products for functional food, dietary supplements, aquaculture feed, and pet food industries.

YUNNAN GREEN A BIOLOGICAL PROJECT CO., LTD. (Yunnan Spirin Biotechnology Co. Ltd) (China)

Founded in 1997 and headquartered in Kunming, China, Yunnan Green is engaged in developing, breeding, producing, and marketing microalgae products. The company’s annual microalgae production capacity, comprising the production of spirulina, chlorella, and Haematococcus Pluvialis, is 3,000 metric tons.

Yunnan Green offers spirulina, chlorella, and Haematococcus pluvialis in the form of powder, tablets, soft capsules, and extract-phycocyanin to the healthcare, medicine, cosmetics, and food industries.

BEIJING GINGKO GROUP (BGG) (U.S.)

Founded in 1997 and headquartered in Kunming, China, Yunnan Green is engaged in developing, breeding, producing, and marketing Haematococcus pluvialis products. The company’s annual Haematococcus pluvialis production capacity, comprising the production of spirulina, chlorella, and Haematococcus Pluvialis, is 3,000 metric tons. Yunnan Green offers its products in the form of powder, tablets, and extract-phycocyanin to the healthcare, medicine, cosmetics, and food industries.

Meticulous Research in its latest publication on Europe Haematococcus Pluvialis Market has predicted the growth of 13.4% during the forecast year 2023-2030.

Atacama Bio Natural Products S.A. (Chile)

Founded in 2003 and headquartered in Pozo Almonte, Chile, Atacama Bio is a private biotechnology corporation that cultures algae to extract healthy ingredients. The company is also an industrial producer of natural astaxanthin obtained from Haematococcus pluvialis microalgae cultures and supplies industrial volumes on a permanent and regular basis. It offers astaxanthin products through its brands REDMEAL and NatAxtin.

Algalíf Iceland ehf. (Part of Sana Pharma Industries) (Iceland)

Founded in 2012 and headquartered in Reykjanesbaer, Iceland, Algalif produces natural astaxanthin from microalgae produced at its state-of-the-art facility in Iceland. The company produces natural antioxidants with a solid scientific foundation and multiple health benefits. It also offers ingredients for nutraceuticals with applications in brain health, eye health, healthy aging, cardiovascular health, muscle endurance/recovery, and skin health.

Algalif offers astaxanthin products in the form of oleoresin, beadlets, powder, and softgel capsules. The company commercializes a range of immune-health ingredients, branded Nutramunity Beta-Glucan (NBG), for food, beverages, nutraceuticals, sports nutrition, and personal care products.

FENCHEM (China)

Established in 1995 and headquartered in Nanjing, China, FENCHEM produces innovative ingredients and product solutions for nutrition & food, cosmetic & personal care, feed & pet food, and paint & construction. The company offers various services, including global sourcing, tailored solutions, custom-made production, and efficient logistics. It also offers natural astaxanthin derived from Haematococcus pluvialis through the nutrition & food and feed & pet food industries.

With its strong distribution network, the company has a geographic presence across North America, Europe, Latin America, Asia-Pacific, and Africa.

Roquette Klötze GmbH & Co. KG (Germany)

Founded in 1995 and headquartered in Klötze, Germany, Roquette produces chlorella with a unique and patented cultivation method in its system of 500 kilometers of glass tubing. The company is also certified by GMP, HACCP, ISO 9001, ISO 22000, ISO 50001, and HALAL.

Roquette Klötze obtains its main raw material, ‘water,’ from an artesian spring, which is water from a depth of over 45 m. It offers chlorella in powder, tablets, pellets, slices, and other forms to the food and beverage industry. The company also offers spirulina in the form of powder and flakes and Astaxanthin in the form of tablets.

Algatechnologies Ltd. (A Part of Solabia Group) (Israel)

Founded in 1998 and headquartered in Kibbutz Ketura, Israel, Algatechnologies is engaged in developing and cultivating microalgae. The company produces nannochloropsis and natural astaxanthin sourced from the microalga Haematococcus pluvialis in the form of oleoresin extract, powder, softgels, and gummies. AstaPure, a brand of the company, caters to the nutrition, food & beverages, and cosmetics industries.

Algatechnologies also provides logistics, warehousing, and lab support services, offering customers a reliable supply and prompt response. With its strong distribution networks across 35 countries, the company has a geographic presence across North America, Asia-Pacific, Europe, Latin America, and the Middle East & Africa,

Popular Mentions: PIVEG, Inc. (U.S.), Sun Chlorella Corporation (Japan), Tianjin Norland Biotech Co., Ltd (China), Sea & Sun Organic GmbH (Subsidiary of Sea & Sun Technology GmbH) (Germany), BDI BioLife Science GmbH (Austria), BlueBioTech Group (Germany), AstaReal Group (Japan), Aliga Microalgae (Denmark), Pond Technologies Inc. (Canada), Algamo s.r.o. (Czech Republic), Algicel, Biotecnologia e Investigação, Lda (Portugal), and Astaxa GmbH (Germany).

Authoritative Research on the Europe Haematococcus Pluvialis Market – Opportunity Analysis and Industry Forecast (2023-2030)

Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:

• Recent financial performance
• Key products
• Significant company strategies
• Partnerships and acquisitions

The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.